Mark R. Witmer

1.6k total citations
29 papers, 893 citations indexed

About

Mark R. Witmer is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Mark R. Witmer has authored 29 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Cell Biology and 6 papers in Oncology. Recurrent topics in Mark R. Witmer's work include Protein Kinase Regulation and GTPase Signaling (8 papers), Cellular transport and secretion (6 papers) and Biochemical and Molecular Research (3 papers). Mark R. Witmer is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (8 papers), Cellular transport and secretion (6 papers) and Biochemical and Molecular Research (3 papers). Mark R. Witmer collaborates with scholars based in United States, Germany and Sweden. Mark R. Witmer's co-authors include Jeffrey Tredup, Rex A. Parker, M.W.C. Hatton, James R. Burke, Peter S. McPherson, Roxane Desjardins, Robert Day, Annik Prat, Nabil G. Seidah and Gaétan Mayer and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Mark R. Witmer

29 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Witmer United States 16 378 293 119 116 108 29 893
Xiang-ju Gu United States 11 522 1.4× 304 1.0× 70 0.6× 116 1.0× 60 0.6× 12 911
David Meininger United States 19 689 1.8× 165 0.6× 216 1.8× 41 0.4× 62 0.6× 22 1.2k
Cynthia D. Sommers United States 17 566 1.5× 88 0.3× 140 1.2× 152 1.3× 83 0.8× 39 1.1k
Ayesha Sitlani United States 18 667 1.8× 537 1.8× 131 1.1× 196 1.7× 120 1.1× 18 1.4k
Richard Sedrani Switzerland 16 783 2.1× 301 1.0× 148 1.2× 343 3.0× 149 1.4× 23 1.6k
Valérie Hindie France 10 877 2.3× 144 0.5× 120 1.0× 76 0.7× 81 0.8× 12 1.3k
Mathias Färnegårdh Sweden 13 531 1.4× 153 0.5× 47 0.4× 105 0.9× 90 0.8× 14 1.1k
Thomas Harrity United States 17 611 1.6× 227 0.8× 31 0.3× 257 2.2× 136 1.3× 23 1.1k
Carl P. Ciosek United States 18 545 1.4× 132 0.5× 40 0.3× 210 1.8× 117 1.1× 23 931
Ted W. Johnson United States 18 790 2.1× 456 1.6× 76 0.6× 395 3.4× 214 2.0× 28 1.6k

Countries citing papers authored by Mark R. Witmer

Since Specialization
Citations

This map shows the geographic impact of Mark R. Witmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Witmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Witmer more than expected).

Fields of papers citing papers by Mark R. Witmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Witmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Witmer. The network helps show where Mark R. Witmer may publish in the future.

Co-authorship network of co-authors of Mark R. Witmer

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Witmer. A scholar is included among the top collaborators of Mark R. Witmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Witmer. Mark R. Witmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiao, Jennifer X., Mark R. Witmer, Tammy C. Wang, et al.. (2023). Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1). Bioorganic & Medicinal Chemistry Letters. 98. 129589–129589. 3 indexed citations
2.
Zhang, Yaqun, Hui Wei, Dianlin Xie, et al.. (2017). An improved protocol for amino acid type-selective isotope labeling in insect cells. Journal of Biomolecular NMR. 68(4). 237–247. 7 indexed citations
3.
4.
Tokarski, John S., Adriana Zupa-Fernandez, Jeffrey Tredup, et al.. (2015). Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain. Journal of Biological Chemistry. 290(17). 11061–11074. 84 indexed citations
5.
Tang, Huaping, Jing Yang, Ding Ren Shen, et al.. (2014). High-Throughput High-Content Imaging Assays for Identification and Characterization of Selective AXL Pathway Inhibitors. Assay and Drug Development Technologies. 12(1). 80–86. 4 indexed citations
6.
Mitchell, Tracy, Ginger Chao, Doree Sitkoff, et al.. (2014). Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering. Journal of Pharmacology and Experimental Therapeutics. 350(2). 412–424. 103 indexed citations
7.
Wrobleski, Stephen T., Shuqun Lin, T. G. Murali Dhar, et al.. (2013). The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode. Bioorganic & Medicinal Chemistry Letters. 23(14). 4120–4126. 15 indexed citations
8.
Gentles, Robert G., S. Sheriff, Brett R. Beno, et al.. (2011). Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 21(8). 2212–2215. 8 indexed citations
9.
Poirier, Steve, Gaétan Mayer, Viviane Poupon, et al.. (2009). Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation. Journal of Biological Chemistry. 284(42). 28856–28864. 223 indexed citations
10.
Locke, Gregory, Dong Cheng, Mark R. Witmer, et al.. (2008). Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate. Archives of Biochemistry and Biophysics. 475(1). 72–79. 16 indexed citations
11.
Watterson, Scott H., T. G. Murali Dhar, Zhongqi Shen, et al.. (2003). Novel inhibitors of IMPDH. Bioorganic & Medicinal Chemistry Letters. 13(3). 543–546. 23 indexed citations
12.
Metzler, William J., et al.. (2003). Kinetic Studies on β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE). Journal of Biological Chemistry. 278(7). 4582–4589. 37 indexed citations
13.
Guenther, Matthew G., Mark R. Witmer, & James R. Burke. (2002). Cytosolic Phospholipase A2 Shows Burst Kinetics Consistent with the Slow, Reversible Formation of a Dead-End Complex. Archives of Biochemistry and Biophysics. 398(1). 101–108. 3 indexed citations
14.
Gu, Henry H., Edwin J. Iwanowicz, Junqing Guo, et al.. (2002). Novel diamide-Based inhibitors of IMPDH. Bioorganic & Medicinal Chemistry Letters. 12(9). 1323–1326. 17 indexed citations
15.
Dubowchik, Gene M., Vivekananda M. Vrudhula, Jonathan L. Ditta, et al.. (2001). 2-Aryl-2,2-difluoroacetamide FKBP12 Ligands:  Synthesis and X-ray Structural Studies. Organic Letters. 3(25). 3987–3990. 92 indexed citations
16.
Burke, James R., Mark R. Witmer, & Jeffrey Tredup. (1999). The Size and Curvature of Anionic Covesicle Substrate Affects the Catalytic Action of Cytosolic Phospholipase A2. Archives of Biochemistry and Biophysics. 365(2). 239–247. 13 indexed citations
17.
Burke, James R., Kurt R. Gregor, Ramesh Padmanabha, et al.. (1998). A β-Lactam Inhibitor of Cytosolic Phospholipase A2which Acts in a Competitive, Reversible Manner at the Lipid/Water Interface. Journal of enzyme inhibition. 13(3). 195–206. 2 indexed citations
18.
Burke, James R., Matthew G. Guenther, Mark R. Witmer, et al.. (1997). Presence of Glycerol Masks the Effects of Phosphorylation on the Catalytic Efficiency of Cytosolic Phospholipase A2. Archives of Biochemistry and Biophysics. 341(1). 177–185. 7 indexed citations
19.
Witmer, Mark R., et al.. (1994). Probing the catalytic roles of n2‐site glutamate residues in Escherichia coli glutamine synthetase by mutagenesis. Protein Science. 3(10). 1746–1759. 3 indexed citations
20.
Witmer, Mark R., Michael P. Weiner, Michael S. Kay, et al.. (1991). U-3′-BCIP: a chromogenic substrate for the detection of RNase A in recombinant DNA expression systems. Nucleic Acids Research. 19(1). 1–4. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiang-ju Gu Breakdown of academic impact, for papers by David Meininger Breakdown of academic impact, for papers by Cynthia D. Sommers Breakdown of academic impact, for papers by Ayesha Sitlani Breakdown of academic impact, for papers by Richard Sedrani Breakdown of academic impact, for papers by Valérie Hindie Breakdown of academic impact, for papers by Mathias Färnegårdh Breakdown of academic impact, for papers by Thomas Harrity Breakdown of academic impact, for papers by Carl P. Ciosek Breakdown of academic impact, for papers by Ted W. Johnson
Rankless by CCL
2026